Who owns First Tracks Biotherapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TRAX from SEC Form 13F filings across 149 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 149 institutions disclosed 34.0M shares of First Tracks Biotherapeutics, Inc. worth $684.6M — about 97.2% of shares outstanding; the largest disclosed holder is EcoR1 Capital, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
149
13F holders
$684.6M
value, 2026 filers
97.2%
of shares outstanding (34.0M sh)
149
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TRAX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | EcoR1 Capital, LLCNEW | 3.2M | $63.9M | 3.1% | 9.1% | new |
| 2 | TCG Crossover Management, LLCNEW | 2.9M | $58.3M | 1.4% | 8.3% | new |
| 3 | FMR LLCNEW | 2.1M | $41.3M | 0.0% | 5.9% | new |
| 4 | Affinity Asset Advisors, LLCNEW | 2.0M | $40.9M | 1.8% | 5.8% | new |
| 5 | BlackRock, Inc.NEW | 2.0M | $39.5M | 0.0% | 5.6% | new |
| 6 | Trails Edge Capital Partners, LPNEW | 1.5M | $30.5M | 4.8% | 4.3% | new |
| 7 | STATE STREET CORPNEW | 1.5M | $30.4M | 0.0% | 4.3% | new |
| 8 | VANGUARD CAPITAL MANAGEMENT LLCNEW | 1.5M | $29.2M | 0.0% | 4.1% | new |
| 9 | Jupiter Topco LLCNEW | 1.1M | $22.0M | 0.0% | 3.1% | new |
| 10 | Vestal Point Capital, LPNEW | 1.0M | $20.4M | 0.5% | 2.9% | new |
| 11 | Woodline Partners LPNEW | 917,176 | $18.5M | 0.1% | 2.6% | new |
| 12 | SanofiNEW | 821,917 | $16.5M | 3.1% | 2.3% | new |
| 13 | MORGAN STANLEYNEW | 781,534 | $15.7M | 0.0% | 2.2% | new |
| 14 | 683 Capital Management, LLCNEW | 750,000 | $15.1M | 0.7% | 2.1% | new |
| 15 | ADAGE CAPITAL PARTNERS GP, L.L.C.NEW | 729,000 | $14.7M | 0.0% | 2.1% | new |
| 16 | Balyasny Asset Management L.P.NEW | 714,948 | $14.4M | 0.0% | 2% | new |
| 17 | GEODE CAPITAL MANAGEMENT, LLCNEW | 702,087 | $14.1M | 0.0% | 2% | new |
| 18 | BANK OF AMERICA CORP /DE/NEW | 647,962 | $13.0M | 0.0% | 1.9% | new |
| 19 | STEMPOINT CAPITAL LPNEW | 622,723 | $12.5M | 2.2% | 1.8% | new |
| 20 | Palo Alto Investors LPNEW | 603,489 | $12.1M | 1.7% | 1.7% | new |
| 21 | Sofinnova Investments, Inc.NEW | 565,199 | $11.4M | 0.6% | 1.6% | new |
| 22 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 546,992 | $11.0M | 0.0% | 1.6% | new |
| 23 | GOLDMAN SACHS GROUP INCNEW | 487,213 | $9.8M | 0.0% | 1.4% | new |
| 24 | Point72 Asset Management, L.P.NEW | 408,330 | $8.2M | 0.0% | 1.2% | new |
| 25 | UBS Group AGNEW | 310,886 | $6.3M | 0.0% | 0.9% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.